Japan’s parliament has made a groundbreaking decision to legalize medicines derived from cannabis, a move celebrated by patient groups. This change, approved in the upper house, allows for the use of cannabis-based medical products, as reported by the South China Morning Post.
The new laws, effective within a year, categorise cannabis and THC (a psychoactive chemical in cannabis) as regulated narcotics. While this permits medical use, it also strengthens Japan’s strict stance on cannabis.
Patients seeking cannabis-based medicines, particularly those containing non-psychoactive CBD, have reason to celebrate. CBD is already used globally to treat conditions like severe epilepsy. (Wion)
The post Japan approves medical cannabis use appeared first on DailyNews.